Abstract
Oxido-inflammatory aberrations play a substantial role in the pathophysiology of depression. Oxido-inflammatory stress increases catabolism of tryptophan into kynurenine which leads to imbalance in kynurenine and serotonin levels in the brain. Naringenin a flavonoid, has been reported to possess antidepressant property by restoring serotonin and noradrenaline levels in the brain. Its effects on oxido-inflammatory aberrations in depression has not been investigated. With this background, the present study was designed to investigate the antidepressant-like potential of naringenin in olfactory bulbectomy (OBX)-induced neuroinflammation, oxidative stress, altered kynurenine pathway, and behavioural deficits in BALB/c mice. OBX-mice showed depression-like behavioural alterations characterized by hyperactivity in open field, increased immobility time in forced swim test and decreased sucrose preference. After 14 days, OBX-mice were treated by gavage with naringenin (25, 50 and 100 mg/kg) and fluoxetine (5 mg/kg) for two weeks. Naringenin significantly ameliorated depression-like behavioural alterations. Naringenin significantly restored corticosterone levels in serum and antioxidant enzymes (Catalase, SOD GSH), nitrite and MDA in ce...Continue Reading
Citations
Jul 18, 2019·Metabolic Brain Disease·Ravinder Naik DharavathKanwaljit Chopra
Jul 14, 2020·Artificial Cells, Nanomedicine, and Biotechnology·Tong LiuWeisheng Feng
May 23, 2020·Scientific Reports·Roberto Farina de AlmeidaDiogo O Souza
Jul 25, 2019·Chinese Medicine·Zhengrong ZhangGuoqi Zhu
Feb 6, 2020·Pharmacological Reports : PR·Akshay KumarKanwaljit Chopra
Jan 12, 2021·European Journal of Integrative Medicine·Yijia ZengQinwan Huang
Aug 16, 2019·Life Sciences·Yun-Feng ZhouQi Chang
Feb 12, 2021·Life Sciences·Ravinder Naik DharavathKanwaljit Chopra
Feb 19, 2021·Neurochemical Research·Shiyana AroraKanwaljit Chopra
Mar 14, 2020·Pharmacology & Therapeutics·Andrea Carlo RossettiRaffaella Molteni
Mar 9, 2021·Frontiers in Neuroscience·Matthew G PontifexDavid Vauzour
May 31, 2020·Life Sciences·Jatinder DhaliwalKanwaljit Chopra
Mar 20, 2021·Metabolic Brain Disease·Shiyana AroraKanwaljit Chopra
Mar 23, 2021·European Journal of Pharmacology·Roshan LalKanwaljit Chopra
Mar 29, 2021·Neurotoxicology·Rupinder Kaur SodhiAnurag Kuhad
Feb 23, 2020·Life Sciences·Raghunath SinghAnurag Kuhad
Jun 30, 2019·Toxicology and Applied Pharmacology·Raghunath SinghAnurag Kuhad
Dec 4, 2020·Aging and Disease·Anwen ShaoJianmin Zhang
Feb 11, 2019·ACS Biomaterials Science & Engineering·Anas AhmadRehan Khan
Jul 8, 2019·ACS Biomaterials Science & Engineering·Md Meraj AnsariRehan Khan